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ABSTRACT
Title: NICU sodium administration to extremely low birth weight infants:
Relationships with recommendations and growth.
Objectives. To determine the amount of sodium being administered in the
Neonatal Intensive Care Unit (NICU) from all sources including parenteral and
enteral nutrition, medications, and intravenous solutions to extremely low birth
weight (ELBW) infants -- those weighing less than or equal to 1000 grams. It was
hypothesized that there are variable amounts of sodium given, but those amounts
are not adequate when compared to the recommendation of the American
Academy of Pediatrics (AAP) (3-5 mEq/kg/d).
Study design. The study design was a retrospective chart review of surviving
ELBW infants admitted to and discharged from the Women and Infants’ Hospital
(WIH) NICU in Providence, Rhode Island from January 2009 through June 2011
who were not enrolled in the NICU protein study. Information on birth weight,
gestational age, length of stay, growth velocity, average protein and calorie intake
per kilogram, and average sodium intake per kilogram received from all sources
was collected for eleven different time points.
Results. Seventy ELBW infants met the criteria for inclusion in this retrospective
chart review. Comparisons of the time points showed the highest amount of
sodium per kilogram to be given at Day of Life 14 (4.52 mEq/kg) and only
twenty-eight infants (40%) received the minimum amount recommended by the
AAP (3-5 mEq/kg) all time points were compared. When analyzed from week 212 (week at which true growth occurs), only eight infants (11 %) of the infants

received adequate amounts. When growth velocity was compared with amount
of sodium received (using 3 mEq/kg as cutoff), more growth was seen in the
group given lower amounts of average sodium with the all-time points set
(12.01±1.5 g/kg/day vs. 10.93±2.64 g/kg/day, p=0.034) and the same was true
in the weeks 2-12 data set but no statistical significance was seen (p=0.84).
Conclusions.

ELBW infants are receiving large amounts of inadvertent

sodium from medications and intravenous solutions. During weeks one and two
of life, 88% and nearly 50% (respectively) of the sodium intake came from
medications or intravenous solutions. Even with the inadvertent amounts of
sodium, most of the infants received suboptimal intakes of sodium compared to
recommendations by the American Academy of Pediatrics (3-5 mEq/kg). Growth
velocity was compared with different levels of sodium (<3 mEq/kg vs ≥3
mEq/kg). More growth was seen in the group with the lower average sodium
than those receiving the higher amount of sodium. This could be explained by
the morbidity level of these infants. When growth rate of the infants who had no
morbidities was compared to those infants with one or more morbidities, greater
growth rates were seen in the group with no morbidities (12.80±1.3 g/kg/day vs.
10.66±2.11, p=0.001).
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CHAPTER 1

INTRODUCTION

Over the last ten years, changes in nutrition practices have improved
growth in extremely low birth weight (ELBW) infants (≤1000 grams) (1). The
American Academy of Pediatrics recommends a postnatal growth rate that
approximates that of a fetus of the same postconceptional age (≥15 g/kg/d) (2).
Changes in nutrition practices include earlier parenteral nutrition, earlier enteral
feeds, continuous feeds, protein fortification of human milk, and the development
of feeding intolerance algorithms. Hanson et al. compared growth pre- and postimplementation of nutrition practice changes and found a decrease in
extrauterine growth restriction (weight that is less than or equal to 10th
percentile) from 57% (pre-implementation) to 28% (post-implementation) (3).
Thiele et al. showed that 73% of these infants grew at or above fetal rates and
had less extrauterine growth restriction (EUGR) compared to those 10 years
prior (1).
While attention has focused on increasing protein and calorie amounts to
avoid growth failure (1,4,5,6), sodium and its requirements for optimal growth
has not been thoroughly investigated even though hyponatremia (defined as a
serum sodium concentration less than 135 mg/dL) is very common in the NICU
and has been implicated as a reason for EUGR (3,7). Sodium is needed for
maintenance of extracellular fluid volume, bone mineralization, protein
1

synthesis, and the transport of glucose across cell membranes (8). As a growth
factor, sodium is important because it stimulates protein synthesis and increases
cell mass and, as a result, inadequate sodium intake could lead to growth failure
(8), and chronic sodium depletion has been found in many conditions related to
failure to thrive (9). Modi suggests that if energy intake is adequate, poor growth
may be associated with sodium depletion even if serum sodium concentrations
are within normal limits (7).
Experimental evidence in both humans and animals suggests that sodium
depletion may in itself be responsible for poor growth (10). The mechanism
whereby sodium promotes growth is not completely understood, but it is
hypothesized that the sodium/hydrogen antiporter system is a likely possibility
(9). The plasma membrane sodium-hydrogen exchanger plays a physiological
role in the regulation of intracellular pH and the control of cell growth and
proliferation and most likely does not function optimally with sodium deficiency
(11).
Wassner and Gallagher investigated sodium deficiency with subsequent
supplementation of sodium chloride in young rats and found improved growth in
the rats that were given sodium supplementation (12,13). Vanpee et al. and AlDahhan et al. conducted studies on preterm infants, giving extra sodium to
infants between day of life four through fourteen and did see improved growth in
those that received sodium supplementation, even after the sodium had been
discontinued (14,15).
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Even when an infant is receiving adequate energy but continues with poor
growth, chronic sodium depletion may be to blame. There have been
documented sodium deficiencies due to ileostomies, cystic fibrosis and various
congenital deformities. Wassner and Kulin gave sodium supplementation to one
boy status post colon resection that was experiencing growth failure and saw a
positive relationship between sodium intake and linear growth (10). Bower et al.
provided sodium supplementation to eleven infants who experienced metabolic
abnormalities caused by ileostomy fluid losses and found a direct relationship
between ileostomy output and the sodium intake required for growth (0.13
mEq/kg/d of sodium for every ml/kg/d of ileostomy input) (16). Sacher et al.
saw similar findings in the retrospective follow up of 30 neonates with
ileostomies (17). In infants with cystic fibrosis, Coates et al. found that none of
the ten infants in his study required more calories than their estimated needs
when their diet was sodium supplemented.
Recommendations by the AAP (1985) for sodium are based on Zeigler et
al.’s factorial method as there are limited studies regarding the optimal amount of
sodium needed for premature infants to promote growth. The factorial method
provides guidelines for all macronutrients and micronutrients and is based on
daily tissue increment, dermal loss, urine loss, intestinal absorption to determine
amounts required. For the 800-1200 g infant (26-28 weeks’ gestation), 3.5
mEq/kg of sodium is recommended (2). Current recommendations have not
altered from Ziegler’s original work and are presented as a range of sodium
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intake (3-5 mEq/kg/d) for infants less than 1000 g from either enteral or
parenteral nutrition (18).
The present study quantified total sodium intakes of 70 ELBW infants
admitted to the Neonatal Intensive Care Unit (NICU) at Women and Infants’
Hospital from January 1, 2009 through June 30, 2011 and compared values to
recommended sodium intakes.
Descriptive analyses and correlations were conducted on variables
including growth velocity, gender, birth weight, total number of morbidities,
nadir serum sodium value, zenith serum sodium value, average calories, average
protein and average sodium (mean and standard deviation). Multiple linear
regressions were done based on correlations with growth velocity as the
dependent variable.
RESEARCH QUESTIONS
Primary: What are the average amounts of sodium being administered to
extremely low birth weight infants in the Neonatal Intensive Care Unit at Women
and Infants’ Hospital, Providence, Rhode Island?
Secondary: 1) Are adequate amounts of sodium being given based on the
recommendations of the American Academy of Pediatrics? 2) Is there a
correlation between average sodium intakes and growth velocity?
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CHAPTER 2

REVIEW OF LITERATURE
Nutrition practices have improved growth rates over the last ten years in
premature infants (1,4,5,6). Despite these improvements, postnatal growth
restriction of extremely low birth weight (ELBW) infants is quite common (4). In
a network cohort study, Ehrankranz found that the majority of ELBW infants
were discharged at weights less than the 10th percentile of expected intrauterine
growth and at 18-22 months’ corrected age, 50% remained below the 10th
percentile (5). There was also an association between poor weight and
neurodevelopment impairment found in this study.
Hanson, et al. compared growth pre- and post-implementation of a
nutrition practice change (3). These changes included earlier parenteral
nutrition, earlier enteral feeds, continuous feeds, protein fortification of human
milk, and the development of a feeding intolerance algorithm. With the new
guidelines, they found a decrease in extrauterine growth restriction (weight less
than or equal to 10th percentile) from 57% (pre-implementation) to 28% (postimplementation) and there was no difference between the groups with regard to
NEC, IVH, or death rates (3).
In a retrospective study of 88 ELBW infants with bronchopulmonary
dysplasia (BPD), Thiele et al. showed that 73% of these infants grew at or above
fetal rates and had less extrauterine growth restriction (EUGR) compared to
those 10 years prior (1). New strategies included early parenteral amino acid
5

administration closer to 3 g/kg/day, earlier initiation of enteral feedings, and
fortification of human milk (19).
EUGR refers to the concept that preterm infants develop a severe
nutritional deficit during the first weeks after birth (20). It has been shown to
correlate negatively with neurodevelopmental milestones at 18 and 24 months’
corrected age (3,5,21). Because of this concern, a primary goal in the NICU is
maintaining adequate growth (≥15 g/kg/day) (20). Complicating this goal are
common morbidities of premature infants including patent ductus arteriosus
(PDA), which is a delay in closure of ductus between aorta and pulmonary artery;
bronchopulmonary dysplasia (BPD) or chronic lung disease of prematurity
(CLD), which is a chronic pulmonary condition; necrotizing enterocolitis (NEC)
which is characterized by abdominal distension, bilious aspirates and/or bloody
stools; and intraventricular hemorrhage (IVH) which is an intracranial bleed
ranging from mild to severe (22,23).
The AAP recommends a postnatal growth rate that approximates that of a
fetus of the same postconceptional age (≥15 g/kg/d) (2). Premature infants with
morbidities tend to grow more slowly than those without morbidities (4). This is
because sick infants’ feeds are interrupted more often, yet they have increased
metabolic needs (20). Premature infants with inadequate sodium intake and
inadequate sodium retention also tend to grow more slowly than those with
adequate sodium intake and retention (22).
More attention has been given to increasing and optimizing
macronutrients (protein and calories) (1,4,5,6), and sodium is not typically
6

examined in most large scale studies of growth in premature infants. When an
infant is meeting their energy needs but continues with poor growth, chronic
sodium depletion may be to blame even with normal or low normal serum
sodium concentration (22). Chronic sodium deficiency has been associated with
poor skeletal and tissue growth (22).
Renal function
Kidneys in newborn infants have a limited capacity to excrete urine and
conserve sodium (7,22). This function occurs in the nephron which is the basic
structural and functional unit of the kidney. Development or growth of the
kidney (nephrogenesis) continues until 36 weeks gestation (24). Because of this,
preterm infants are likely to have a reduced number of nephrons and therefore a
decreased glomerular filtration rate (25). After extracellular volume contraction
occurs, the preterm infant is vulnerable to sodium depletion secondary to
immature sodium reabsorption (25).
Diuresis
Preterm infants less than 26 weeks’ gestation are approximately 80-90%
water (7). After birth, there is a sudden efflux of fluid from the intracellular fluid
(ICF) compartment to the extracellular fluid compartment (ECF) (22,26). The
ECF consists mainly of water and sodium and with this increase in the ECF, the
neonatal kidneys are flooded, resulting in salt and water diuresis by two to three
days which amounts to weight loss of between 10-15% of birth weight during the
first 5 days of life (26), and this percentage could even be as high as 20% (25).
There is an inverse relationship between birth weight and weight loss percentage
7

during diuresis (26). Failure to lose this fluid could result in overhydration and
possibly lead to PDA and CLD (23).
Adverse effects
Adverse effects of excess sodium administration can be seen in the first
few days of life and can increase the risk of hypernatremia (serum sodium >150
mg/dL) especially if fluids are limited. In a retrospective study of infants less
than 27 weeks’ gestation, nearly 70% of hypernatremic infants developed CLD,
PDA and IVH (23). After diuresis, though, ELBW infants are at risk for chronic
sodium depletion, and an intake of at least 4 mEq/kg/day is required (7).
Sodium is an important nutrient for preterm infants and is needed for
maintenance of extracellular fluid volume, bone mineralization, protein
synthesis, and the transport of glucose across cell membranes (8). As a growth
factor, sodium is important because it stimulates protein synthesis and increases
cell mass (9). As a result, inadequate sodium intake could lead to growth failure
(8). Chronic sodium depletion may be found in many conditions related to failure
to thrive (9).
Hyponatremia (defined as a serum sodium concentration less than 135
mg/dL) is not always seen as the primary reason for growth restriction, but it is
very common in the NICU and has been implicated as a reason for EUGR (3,7).
Modi suggests that if energy intake is adequate, poor growth may be associated
with sodium depletion even if serum sodium concentrations are within normal
limits (7). Experimental evidence in both humans and animals suggests that
sodium depletion may in itself be responsible for poor growth (10).
8

Sodium requirements
Sodium requirements vary on day of life. Because of the prediuretic status
of the baby, on day of life 0, a negative sodium balance is desired and only 0-1
mEq/kg/day of sodium is recommended (7). For the transition period
(extracellular water contraction and weight loss) on days 1-5 of life, 2-5
mEq/kg/day of sodium are recommended (30). According to the AAP (18),
current recommendations for the growing low birth weight infant are 3-5 mEq of
sodium, which was first calculated by the reference fetus of Ziegler et al (6),
although up to 7 mEq may be needed for babies experiencing late hyponatremia
(27). Goals may be underestimated because net gastrointestinal absorption of
enteral feeds is approximately 70% (26). Further complicating this goal is that
very preterm infants have lower intestinal absorption of sodium or higher
urinary losses than estimated (28).
Some institutions give 4-6 mEq/kg/day of sodium on the second or third
day of life (DOL) regardless of clinical status (29). Hartnoll et al. and Al-Dahhan
et al. recommended delaying sodium supplementation until DOL 4-5 or until 6%
weight loss occurs to allow for fluid contraction (28,30). Bhatia recommends no
additional sodium until serum sodium is <130 mg/dL, then starting with 2-3
mEq/kg/day (31).
Animal Studies
Wassner studied the effect of supplementing sodium-deficient young rats.
Both the experimental and control groups received similar diets and distilled
water for 2-3 weeks but the experimental group received 37 mEq of sodium
9

chloride. The control group gained just 45% and 70% of weight and length,
respectively, compared to the experimental group suggesting growth failure with
sodium deficiency (12).
Gallagher et al. also studied diet-induced sodium deficiency and measured
the lung growth of young rats after undergoing left pneumonectomy (13). As
above, experimental and control groups were fed similar diets and distilled
water, but the control group received 37 mEq of sodium chloride. After the 7
days, somatic growth was measured as well as lung mass, and it was shown that
the sodium-deficient rats grew more slowly than the rats in the experimental
group (13).
Infant Studies
As mentioned earlier, there is concern that early sodium supplementation
could delay diuresis and therefore further increase expansion of extracellular
compartment which, in turn, could affect the lungs and heart. Early sodium
administration could be possibly harmful and should be avoided until diuresis
occurs (7). Hartnoll et al. (2000) studied oxygen dependency and timing of
sodium supplementation. Twenty-four preterm infants of 25-30 weeks’
gestational age (weight range 745-1560 g) received sodium supplementation
(sodium chloride) before six percent of birth weight was lost (experimental
group), and delayed sodium supplementation in twenty-two infants (weight
range 420-1570 g) until 6% body weight was lost (control group) (30). The
delayed sodium group had a large maximum weight loss than the early group
(16.1% vs. 11.4%, p=0.02) but they saw no significant differences in time to
10

regain birth weight, weight at 36 weeks, nor six months of postmenstrual age.
There was also a significant difference in oxygen requirement at seven days with
35% of delayed group on room air compared with only 9% of early group on
room air. They concluded that delaying sodium supplementation until 6% of
birth weight is lost is beneficial for lungs and did not compromise growth (30).
Elstgeest et al. retrospectively compared two cohorts of infants <28 weeks
who received either early TPN administration or late TPN administration (29).
Due to a change in clinical practices, TPN was either started on day of life 0 or 1
at 60-80 ml/kg (early TPN) or day of life three at 80-120 ml/kg (late TPN). The
early TPN group also received electrolytes within the first day of life. They saw
no statistically significant differences in sodium levels (141.8±3.8 vs. 141.0±3.7
mEq/L), although loss of body weight was decreased in the early TPN group (6.0%±7.7 vs. -0.8%±8.0%). They also found a higher weight gain in the early
TPN group at day of life 14 and 21, but attributed this to increased protein
administration, not sodium.
Vanpee et al. (1995) studied twenty premature infants (gestational age
29-34 weeks) at the Karolinska Hospital in Sweden. Ten of the infants were
randomly chosen to receive an additional 4 mEq of sodium chloride per kilogram
from day of life 4 to day 14 of life, which amounted to total sodium amounts of
5.0±0.9 mEq Na/kg (14). The non-supplemented group received 1.7±0.6
mEq/kg/day of NaCl. Both groups were studied at one and two weeks of age. No
significant differences between the two groups were seen in gestational age, birth
weight, and total fluid intake. At one week, the sodium supplemented group was
11

in positive sodium balance compared to the nonsupplemented group and also
had higher sodium balance at two weeks. Weight loss was greater in the control
group at one week, and at two weeks, most of the control group had not returned
to their birth weights. Even after sodium supplementation was discontinued, the
experimental group’s growth velocity was greater. Diuresis and water excretion
were similar in both groups at week 1 and 2. None of the supplemented babies
had serum sodium levels greater than 145 mg/dL suggesting tolerance of
increased sodium amounts (14).
Al-Dahhan et al. (1984) conducted a randomized control trial that studied
the clinical and biochemical effects of sodium supplementation given to twentytwo otherwise healthy infants between 27-34 weeks’ gestational age from day of
life 4 to 14 compared with a group of 24 unsupplemented babies (28). Birth
weight was regained more quickly in the supplemented infants, and they lost less
weight postnatally, and their improved weight gain (g/kg/day) continued even
after supplementation was discontinued. Unsupplemented infants also
experienced a significantly greater incidence of hyponatremia compared with the
supplemented group. No edema, hypernatremia, or evidence of circulatory
overload was seen. There was no significant difference in incidence of PDA, NEC,
or IVH (28).
Al-Dahhan et al. (2002) conducted a secondary analysis of previously
sodium-supplemented infants (n=37) studying the effects of sodium
supplementation on neurodevelopmental outcomes of 10-13 year olds. Some of
these adolescents had received sodium supplements on DOL 4-14 while
12

inpatients in a NICU (15). They found that nine infants in the unsupplemented
cohort had had plasma sodium levels of <130 mg/dL compared to four infants in
the supplemented group. The supplemented infants performed significantly
better in balance and manual dexterity. The supplemented group also had higher
verbal intelligence quotients, and significantly different performance and full
scale intelligence quotients. Children in the unsupplemented group were also
more than likely (p <0.07) than the unsupplemented group to have behavioral
disturbances (15).
CASE STUDIES
Several case reports identify a correlation between sodium depletion and
poor growth. Wassner and Kulin identified a boy status-post colon resection that
occurred at one year of age (10). One month after the surgery, he was admitted
with an ileus and his serum sodium level was 119 mEq/L. When seen again at 7
years of age, his weight and height were below the 5th percentile on growth
charts. Sodium supplementation was begun and an increase in linear growth was
seen. When sodium intake was compared to growth per month, a significant
correlation was seen (p<0.025) (10).
In a neonates with grade 3 Pierre Robin Sequence (a congenital condition
of facial abnormalities, a retrospective chart review was conducted by Skillman et
al. on infants born between 2000-2007 at a tertiary center for cleft palate care
(32). Twenty-nine infants who required nasogastric or nasopharyngeal
intubation were included in the study. After supplementation in 18 of the 21
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infants who had low urinary sodium, weight gain improved significantly from 20
to 24 g/day (p=<0.001) (32).
Sodium deficits can also be seen in infants with ileostomies. Excessive
sodium loss can occur with ileostomies because of poor or absent colon function
(which helps retain fluid and sodium). Bower et al. reviewed the records of
eleven infants who were 25 to 38 weeks' gestation who experienced metabolic
abnormalities caused by ileostomy fluid losses. All these infants developed total
body sodium depletion and metabolic acidosis from ileostomy bicarbonate loss.
After sodium supplementation, however, these infants gained weight and a direct
relationship was seen between ileostomy output and the sodium intake required
for growth (which was calculated as an extra 0.13 mEq/kg/d of sodium for every
ml/kg/d of ileostomy input) (16).
Sacher et al. saw similar findings in the retrospective follow up of 30
neonates with ileostomies (17). Because enteral products provide just 2-4
mEq/kg of sodium, a sodium deficiency can amount to 4-6 mEq/kg a day with
these patients. After this amount was supplemented in the thirty infants, better
growth was seen.
Infants with cystic fibrosis are at higher risk for sodium depletion which
can lead to impaired growth. In a study of ten cystic fibrosis patients, weights
and plasma/urine sodium were obtained serially (33). The amount of sodium
supplementation was determined by fractional excretion of sodium and urinary
sodium. Coates et al. found that no infant required more calories than estimated
needs when their diet was sodium supplemented.
14

LATE HYPONATREMIA
Late hyponatremia (low serum sodium levels after two weeks of age) has
been observed in very low birth weight infants (birth weight of ≤1500 g) when
they received 2-3.5 mEq/kg/day of sodium (34). As these low birth weight
infants transition from parenteral to enteral nutrition, sodium intake decreases
while sodium requirements increase secondary to their growing more rapidly.
This is further complicated by sodium losses during the initial weeks of life
secondary to their kidneys’ ability to retain sodium (34).
Roy el al. conducted a study of 46 very low birth weight infants between
two to six weeks of age (35). The nonsupplemented infants received less than 2
mEq of sodium per kg/day. The supplemented infants received ~3 mEq of
sodium/kg/day. Hyponatremia was seen on 54 of 159 occasions in the infants
receiving sodium amounts of ≤2 mEq/kg/day.
In a retrospective cohort study in 1996, Kloiber et al. examined data
obtained from medical records of VLBW infants admitted to their NICU who
experienced late hyponatremia (serum sodium <135 mg/dL between days of life
14-56) (8). There was an association between babies less than 1000 g and late
hyponatremia, even though these infants received more sodium than the other
infants. This might have suggested a sodium deficiency and the need for
increased sodium in these ELBW infants. Because of this, Kloiber et al. estimated
sodium requirements of ELBW infants at three to eight mEq/kg/day.
Infants less than 1500 grams are prone to development of hyponatremia
which can lead to increased mortality and morbidity (36). Ndwiga et al assigned
15

56 very low birth weight infants (1000-1500 g) to either an acutely ill group or
clinically stable group. The ill infants had persistently low serum sodium (mean
of 120 mmol/L) during the first week while the clinically stable infants’ sodium
levels increased from 127 to 133 mmol/L. At day seven, there was a statistically
significant difference in serum sodium levels (p=0.02).
Unsupplemented breast milk may not be appropriate for low birth weight
infants. Ayisi et al. conducted a sodium supplementation study in 66 healthy
infants who weighed between 1001-1500 grams at Kenyatta National Hospital
Newborn Unit in Kenya (37). Forty one infants were supplemented with sodium,
while the twenty five in the control group were unsupplemented. Serum sodium
levels were measured in both groups during the 6-week study period. Feedings
were started at 60 ml/kg/day on day 1 and at day 7, 3 mEq/kg/day of sodium
was supplemented for a total of 5.95 mEq/kg/day during the 5 consecutive
weeks of supplementation, while sodium for the unsupplemented group was 2.75
mEq/kg/day. There was a statistically significant difference in the amount of
sodium each group received (p < 0.01), although no significant difference was
seen in mean serum sodium levels in both groups (140 ± 2 mEq/L vs. 139±+2
mEq/L respectively). Statistically significant differences were seen in weight,
length, and head circumference in the group supplemented with sodium
compared with the unsupplemented group (37).
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MECHANISMS
The mechanism whereby sodium promotes cell growth is not completely
understood, but it is hypothesized that the sodium/hydrogen antiporter system
which controls the cell interior pH is a likely possibility (9).
The sodium/hydrogen (Na+-H+) exchanger has been documented in the
plasma membrane of a wide variety of cell types and is a carrier-mediated Na+H+ exchange (antiport, countertransport) system that exchanges sodium for
hydrogen (11). In the intact cell, the plasma membrane Na+-H+ exchanger
controls the extrusion of protons and flux of Na+ into the cell. This process does
not need a chemical reaction (such as ATP hydrolysis) but energy is obtained
from the Na+ gradient, which is maintained by the active extrusion of Na+ by the
Na+,K+- ATPase system. This plasma membrane sodium-hydrogen exchanger
plays a physiological role in the regulation of intracellular pH and the control of
cell growth and proliferation (11) and most likely does not function optimally
with sodium deficiency.
All sodium transporting and regulating systems undergo maturation in the
postnatal period. Active sodium transport in all eukaryotic cells is provided by
the Na+,K+-ATPase enzyme (25). This transmembrane protein controls the
electrochemical sodium and potassium gradient of the cell membrane. Short
term regulation of sodium balance is controlled by activity of sodium
transporters. Natriuresis is caused when these are down regulated by either
atrial natriuretic peptide, dopamine, or diuretics. Sodium retention occurs when
these are upregulated by noradrenaline.
17

CHAPTER 3

METHODOLOGY

A retrospective chart review was conducted after approval by Women and
Infants’ Hospital and the University of Rhode Island.
Inclusion criteria for the study included birth weight less than or equal to
1000 g and survival past 36 weeks gestational age. Exclusion criteria included
expiration prior to 36 weeks, admission into the NICU protein study, and transfer
from another facility.
Detailed patient information was extracted from patient medical records
and parenteral nutrition software. This information included birth weight,
gestational age, length of stay, growth velocity, average protein and calorie intake
per kilogram, and average sodium intake per kilogram received from all sources.
These sources included enteral and parenteral nutrition, medications, and
intravenous solutions. The time points for data extraction included day of life
one (1), four (4), seven (7), fourteen (14), twenty-one (21), twenty-eight (28),
thirty-five (35), forty-two (42), fifty-six (56), seventy (70) and eighty-four (84).
Presence of the following diagnoses was noted: intraventricular
hemorrhage (IVH), necrotizing enterocolitis (NEC), chronic lung disease (CLD),
patent ductus arteriosus (PDA) and were extracted from diagnoses list on the
electronic medical record. It has been shown that infants less than 1500 g with
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one or more of these morbidities have a slower growth rate than the growth rate
of infants who were not diagnosed with any of these morbidities (4).
ELBW Database
At WIH, data from infants less than or equal to 1000 grams are entered
into the ELBW database located in Microsoft Access. The purpose of a nutrition
database for ELBW infants is to ensure that nutritional goals for this vulnerable
group are being met. ELBW infants have high nutritional needs and are at high
risk of nutrition-related morbidities such as infection, necrotizing enterocolitis,
chronic lung disease, and poor growth. The information recorded includes
weight, IV fluids, parenteral nutrition, and enteral nutrition including additives.
These data are collected on days of life 1, 4, 7, 14, 21, 28, 35, 42, 56, 70, and 84.
Queries are used to determine the total calories, total protein, and total fluids per
kilogram at these different time points, and these results were used for this
study.
Sodium from Parenteral Nutrition
Parenteral nutrition (PN) is provided to infants from the first or second
day of life until transitioned to full enteral feeds. Orders are written by the
neonatal nutritionists utilizing Abacus Pharmaceutical Software (Version 2) after
review by the interdisciplinary team and are based on laboratory data, diagnoses,
and clinical status. A new table was created in the ELBW database to enter
sodium intake, and queries were used to calculate sodium in mEq/kg at all the
time points. The data abstraction tool that was used to collect this information
from Abacus is found in Appendix B.
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Sodium from Enteral Nutrition
Information about enteral nutrition was extracted from the queries
already created in the ELBW database in Microsoft Access. Different queries
were used to calculate the amount of protein, calories, and sodium per kilogram
that is contained in the appropriate formula. Formula composition information
was obtained from the manufacturers and this information was already in place
in the database. Nutrition composition of enteral feeds can be found in Appendix
A.
Sodium from Intravenous Solutions and Medications
At the chosen time points, sodium-containing IV solutions and all
medications administered were documented using another data abstraction tool
which can be found in Appendix B. The amount in milliliters of each intravenous
solution and medication was collected. These values were then entered into the
ELBW database in Microsoft Access and queries were used to determine sodium
milliequivalents per kilogram.
Information about sodium content of medications was obtained from the
manufacturers, from literature, and the pharmacy department at WIH. Several
medications are prepared in the pharmacy or at the bedside using normal saline,
so even though the medication may not contain sodium, the administered dose
will contain sodium because of its preparation. A table depicting the
medications, IV solutions and amounts of sodium per 100 ml can be found in
Appendix C.
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Determining sodium levels from heparin was particularly difficult.
Heparin that is added to intravenous solutions is a fraction of the entire bag.
Together with Pharmacy, a calculation was used to represent heparin as a
percentage of the total bag based on the amount of units/bag. This can also be
found on the Medication Sodium List found in Appendix C.
Serum Sodium Values
Serum sodium values that were available at the time points were
collected. Because this was a retrospective study, not all infants had serum
sodium levels at all the time points. Also collected were the nadir and zenith
serum sodium values as well as what day of life they were drawn.
Calculating Growth Velocity
The growth velocity values used in the statistical analysis were calculated
for each infant utilizing the two point method (38) which is shown below:
Growth Velocity = W2 - W1 ÷D ÷ W3, where
W2 = Weight at last week measured (g).
W1 = Birth weight (g) divided by
D = The number of weeks (converted to days) that data were
collected.
W3 = W2 + W1/2
Z-Scores
At WIH, the Fenton Growth Chart is used as a tool to monitor growth while
on the NICU, and this particular version is used for both males and females. This
growth chart highlights the 3rd, 10th, 50th, 90th, and 97th percentiles and is in place
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in the electronic medical record. Any weight not at the 50th percentile is
considered a particular “distance” away from the median – or certain “z-score”
away from 50th percentile. For example, using percentiles, an infant could be
plotted on the chart and described as weighing less than the 3rd percentile.
When using z-scores, the infant’s weight is described more precisely as having a
z-score of -2.7. Using z scores is another tool to examine growth patterns. Zscores less than -1.28 are considered growth restricted (3).
Statistical Analyses
All of the data were consolidated into Microsoft Access 2010 (Seattle, WA),
allowing extraction of the data from different sources for statistical analyses.
Statistical analyses were done using SPSS Version 21 (IBM Corporation, Armonk,
NY).
The data were analyzed two ways. First, all data points were used (days of
life 1, 4, 7, 14, 21, 28, 35, 42, 56, 70 and 84) and these data underwent analysis
using correlations, independent t-tests, and regression. Because in
uncomplicated cases, actual growth is not expected until after day of life 14 (2),
the data were also analyzed from Week 2 through Week 12 with the same
statistical tests.
Growth velocity, birth weight, nadir serum sodium value, zenith serum
sodium value, average calories, average protein and average sodium intake were
described using standard descriptive statistical methods (mean and standard
deviation). Normality for all variables was examined using the Shapiro Wilk test
although because the sample size was 70 infants, normality was assumed using
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the Central Limit Theorem which states that if sample size is greater than 30, the
sample distribution can be safely assumed as normal (39).
Analyses of variance were performed on growth velocity vs. morbidities
and average sodium intake for both sets of data (all time points and weeks 2-12).
They were also performed on average inadvertent sodium intake and morbidities
as well as average calorie intake and morbidities. P<0.05 was considered
significant.
Pearson correlations were run between average sodium, protein, and
calorie intake, gestational age, birth weight and growth velocity at the specific
time points as a means of exploring possible relationships. This was used to
provide a basis for variables that were entered into a multiple linear regression.
The initial analysis is a description of average sodium, protein, and calorie
intake per kilogram from all sources and average weight. Sodium intake
averages were compared to recommendations set forth by the American
Academy of Pediatrics.
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CHAPTER 4

FINDINGS

RESULTS
Study Population
One hundred eighty nine (189) extremely low birth weight infants were
admitted to the Neonatal Intensive Care Unit at Women and Infants’ Hospital in
Providence, Rhode Island from January 1, 2009 through June 30, 2011. Of these,
eighteen (18) were transferred from other hospitals, forty two (42) expired prior
to week 12 of life, and fifty-eight (58) were enrolled in the NICU protein study,
and one (1) was excluded because the electronic medical record was locked by
the family and data could not be collected. Seventy ELBW infants satisfied the
inclusion criteria for the study. All babies were hospitalized in the NICU through
at least 35 days of life. The sample remained essentially stable throughout the
first six weeks of life, and three infants were discharged by day 42 (Figure 1).
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Figure 1. Number of study infants at different time points.
Characteristics of infants enrolled in the study are presented in Table 1
including birth weight, gestational age, length of stay, and gender. Fifteen infants
(21%) were considered small for gestational age (SGA) weight -- plotted less than
10% percentile on the Fenton Growth Chart or z score <-1.28 (indicating they
were more than 1.28 standard deviations below the population mean). Average
calories, sodium, protein and growth velocity for both sets of time points (all time
points and week 2-12 time points) can be found in Table 2.
When comparing average sodium intake of the infants at all the time
points, the most average sodium per kilogram was given at day 14 (4.52 mEq/kg)
(Figure 2). Average sodium, protein, and calories received by the study infants
individually can be visualized in Figures 3, 4, and 5.
Available labs for serum sodium (mmol/L) revealed that there were
twenty five infants (36%) who experienced hyponatremia (serum sodium <130
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mmol/L) and fourteen infants (20%) that experienced hypernatremia (serum
sodium >150 mmol/L).
Variable

Mean ± SD
or n (%)
Birth Weight (g)
777±151
Gestational Age (weeks)
26.4±2.12
Length of Stay (days)
104±47.4
SGA
15 (21%)
Male
31 (44%)
Female
39 (56%)
Table 1. Descriptive characteristics of infants included in study.
All Time Points
(n=70)

Variable

Time Points
starting at Week 2
(n=70)
Mean
Std Dev

Mean

Std
Dev
Avg Calories (cals/kg)
101.5
8.8
116.1
12.2
Avg Sodium (mEq/kg)
2.97
0.69
2.1
0.59
Avg Protein (g/kg)
3.3
0.25
1.8
0.06
Growth Velocity (g/kg/d)
11.58
2.09
10.7
1.8
Table 2. Mean ± standard deviation of average calories, sodium, protein, and
growth velocity for both time point sets.
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Figure 2. Average sodium intake of all infants (mEq/kg/day) at different time
points.
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Figure 3. Individual average sodium intake (mEq/kg/d) of study infants.

Figure 4. Individual average protein intake (g/kg/d) of study infants.

27

Figure 5. Individual average calorie intake (kcal/kg/d) of study infants.
Growth Velocity vs. Sodium Group
Growth velocities (g/kg/d) were compared between those infants
receiving ≥3 mEq/kg of sodium and those receiving <3 mEq/kg of sodium using
an analysis of variance with both sets of data (all time points and weeks 2-12). In
the all-time point set, 42 infants (60%) received an average of less than 3 mEq/kg
of sodium and had a mean growth velocity of 12.01± 1.5 g/kg/day. Twenty-eight
infants (40%) received an average sodium intake of ≥3 g/kg/day and had a mean
growth velocity of 10.93±2.64 g/kg/day. There was a significant difference found
between the two groups (p=0.034) (Figure 6). When time points from only
weeks 2-12 were included, 62 infants (89%) received an average sodium intake
of <3 mEq/kg and only eight infants (11%) received an average sodium intake of
≥3 g/kg/day. No statistical significance was seen between groups (p=0.8376).
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Figure 6. Growth Velocity vs. sodium level [<3 mEq/kg (group 1) or ≥3
mEq/kg (group 2)] all time points.
Average Sodium Intake vs. Morbidities
Thirty infants had no morbidities (43%) and 40 infants (57%) had one or
more morbidity. An ANOVA was performed between average sodium intake
(mEq/kg/d) and infants with no morbidities and those with one or more
morbidities in both time-point sets. In the all-time-point set, there was a
significant difference between the amount of sodium received and the number of
morbidities [2.7 ±0.51 mEq/kg (none) vs. 3.16±0.75 mEq/kg (1-3 morbidities),
p=0.0064] (Figure 7). In the Weeks 2-12 data set, no statistical significance was
seen between amount of sodium received no morbidities vs 1-3 morbidities
(p=0.61).
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Figure 7. Total number of morbidities vs. average sodium (mEq/kg) all time
points. Group 0 = no morbidities; Group 1 = one or more morbidity.
Growth Velocity vs. Number of Morbidities
An ANOVA was performed comparing growth velocity between those
infants with no morbidities and those with one or more morbidities. In the alltime-point group, a significant difference was seen between the two groups
(12.80±1.3 g/kg/d vs. 10.66±2.11 g/kg/d, p=0.001) (Figure 8). In the 2-12 week
time point group, no significant difference was seen (p= 0.0742).
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Figure 8. Total number of morbidities vs. growth velocity (all weeks). Group 0 =
infants with no morbidities; Group 1 = infants with 1-3 morbidities.
Average Calories Intake vs. Morbidities
Average calorie intake (kcal/kg/d) was compared with two levels of
morbidities (none or 1-3) for both time point data sets. In the all-time point
group, there was a significant difference between those infants without
morbidities compared with those infants with morbidities (104±7.72 kcal/kg/d
vs. 99.8±9.2 kcal/kg/d, p=0.036) (Figure 9). In the time point data set from 2-12
weeks, a significant difference was also seen between those infants without
morbidities and those infants with one or more morbidity (119.44 kcal/kg/day
113.6 kcal/kg/day, p=0.047) (Figure 10).

31

Figure 9 Average Calorie Intake vs. Morbidities for all time points. Group 0 = no
morbidities and group 1 = 1 – 3 morbidities.

Figure 10 Average Calorie Intake vs. Morbidities for time points weeks 2-12.
Group 0 = no morbidities and group 1 = 1 – 3 morbidities.
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Average Inadvertent Sodium Intake vs. Morbidities
Average inadvertent sodium intake was compared with the two morbidity
sets (no morbidities vs. 1-3 morbidities). The thirty infants without morbidities
received 0.39±0.32 mEq/kg/d of sodium via medications and/or intravenous
solutions. The other 57% of the infants (1-3 morbidities) received 0.83±0.58
mEq/kg/day of sodium. This revealed a significant difference (p=0.0005).
(Figure 11). In the Week 2-12 data set, the thirty infants without morbidities
received 0.104±0.22 mEq/kg/d of sodium via medications and/or intravenous
solutions. The other 40 infants with 1-3 morbidities received 0.35±0415
mEq/kg/day of sodium. This also revealed a significant difference (p=0.044).

Figure 11 Number of morbidities compared with average inadvertent sodium
intake (mEq/kg/d). Group 0 = no morbidities and group 1 = 1 – 3 morbidities.
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Pearson Correlations
Pearson correlations were conducted between variables growth velocity;
average protein, average sodium, average calories, and birth weight) in the All
Time Point data set. Non-significant correlations were seen between growth
velocity and average protein (r=-0.010). Moderate correlations and statistical
significance were seen between growth velocity and average sodium (r=-0.319;
p=0.007); average calories (r=0.399,p=0.001); and birth weight (r=0.332,
p=0.005). In the Week 2-12 data set, no significant correlations were seen, thus,
no regression analysis was done with this time-point grouping.
Normality
Normality for all variables was examined using the Shapiro Wilk test.
Results of this testing is presented in Table 3. While only growth velocity,
protein, and calories were considered normally distributed in the all-time point
group and only sodium and calories were considered normally distributed in the
weeks 2-12 group, normality was assumed for all variables because of the large
sample size citing the Central Limit Theorem (39).
Variable

All Time Points
Weeks 2-12
Shapiro
P
Shapiro
P
Wilk
value
Wilk
value
Growth Velocity 0.98
0.47
0.83
<0.001
Protein
0.98
0.34
0.87
<0.001
Sodium
0.92
0.004
0.97
0.28
Calories
0.99
0.89
0.99
0.97
Birth weight
0.95
0.01
0.95
0.01
Gestational Age 0.92
0.001
0.92
0.001
Length of Stay
0.91
0.001
0.91
0.001
Table 3. Results of the Shapiro Wilk analyses
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Regression
A multiple linear regression was used to test if average sodium intake
significantly predicted growth velocity. The original model contained growth
velocity (dependent variable), average sodium intake (mEq/kg/d), average
calorie intake (kcal/kg/d), and average protein intake (g/kg/d). The results of
this regression indicated that the three predictors explained 22% of the variance
[R2=0.22, F(3,66)=6.16, p=0.009]. Average protein showed no significance and
was removed from the model (Table 4).
The final model included growth velocity (dependent variable), average
sodium intake and average calories. The results of this regression indicated that
the two predictors explained 20% of the variance [R2=0.20, F(2,67)=8.71,
p=0.004] (Table 5).
Variable

Parameter
Estimate
Intercept Intercept
1
8.08
X1
Avg Protein
1
-0.96
X2
Avg Sodium
1
-0.702
X3
Avg Calories 1
0.086
Table 4. Parameter Estimates Original Model
Variable

Label

Label

DF

DF

Parameter
Estimate
Intercept Intercept
1
5.49
X1
Avg Sodium
1
-0.69
X2
Avg Calories 1
0.0799
Table 5. Parameter Estimates Final Model.
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Standard
Error
4.07
0.94
0.345
0.027

t
value
1.99
-1.02
-2.03
3.12

Pr > t

Standard
t
Error
value
3.178
1.73
0.345
-1.99
0.0268
2.98

Pr > t

0.05
0.31
0.045
0.003

0.09
0.50
0.004

CHAPTER 5

CONCLUSION

In this retrospective cohort study, it was shown that sodium intake of
ELBW infants is suboptimal when compared to the AAP recommendations
derived by Zeigler et al’s factorial method and the more recent recommendations
of the AAP which is 3-5 mEq/kg/d) (2,18). Comparisons of the time points
showed the highest amount of sodium per kilogram to be given in the first two
weeks of life, and the most was given on day of life 14 (4.52 mEq/kg). This could
be related to antibiotics given during that time -- antibiotics that contain large
amounts of sodium in their preparation (i.e. ampicillin). Other inadvertent
amounts of sodium are administered from arterial lines (which are infused with
normal saline), blood products, and resuscitation fluids.
Because more sodium, medications, and blood products are given during
the first two weeks of life and because real growth occurs after week two (2), the
data were also analyzed from week two through twelve. When all time points
were compared with the amount recommended by the AAP (3-5mEq/kg), only
twenty-eight infants (40%) received the minimum amount. When analyzed from
weeks 2-12, only 11% of the infants received the minimum amount
recommended.
Both sets of time point data were then split into two groups in order to
compare growth velocity with amount of sodium received using 3 mEq/kg as a
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cutoff. When comparing data from all the time points, a faster growth rate was
seen in the group given lower amounts of average sodium (12.01± 1.5 g/kg/day
vs. 10.93±2.64 g/kg/day, p =0.034) and the same was true using weeks 2-12
although not statistically different. One could assume that this is related to these
infants having one or more morbidities. When growth rate of the infants who
had no morbidities was compared to those infants with one or more morbidities,
greater growth rates were seen in the group with no morbidities (12.80±1.3
g/kg/day vs. 10.66±2.11, p=0.001)
Surprisingly, average protein intake did not appear to be correlated to
growth velocity in this sample although other studies have supported such a
relationship (4,8). It may have been because many of the infants received close
to adequate protein amounts (~3 g/kg/d). In the present study, growth velocity
seemed to be better explained by caloric intake rather than sodium or protein
intake. It is worth noting that growth velocity averaged only 11.58±2.09
g/kg/day (all time points) and 10.7±1/8 (weeks 2-12), which is substantially
below the 15 g/kg/day recommended by AAP (2). Furthermore the factorial
method of estimating needs assumes 130 calories, and the infants in this study
averaged only 101.5±8.8 kcal/kg (all time points) and 116.10±12.2 kcals/kg
(weeks 2-12). It is also noteworthy that when comparing z scores from birth to
discharge, only 7 of the infants (10%) increased their z score while hospitalized.
This further strengthens the thought that there is still additional work to be done
to improve growth outcomes.
When exploring gender and growth velocity, there was a statistical
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difference seen between gender and growth velocity in the all-time point
grouping (p=0.035). Because the NICU at WIH utilizes just one growth chart
(Fenton) (40), a decision was made not to control for this in the analyses.
In the final regression model, average sodium was not a predictor of
growth velocity, and it appeared that average calorie amount may have been
more important in predicting growth velocity.
LIMITATIONS AND STRENGTHS
Because blood draws are kept to a clinically-necessary minimum in the
NICU to reduce the need for blood transfusions, serum sodium values were not
available on all babies at all-time points in the way needed for a research study
about sodium intake. This also assumes that serum sodium levels are the best
way to assess sodium balance in preterm infants. Flushes received at the
bedside were not counted in this study as they are not documented in the
electronic medical record yet registered nurses do this routinely. The strengths
of this study included the sample size and consideration of multiple factors that
may impact growth velocity in ELBW infants. Examining sodium from all sources
across the entire length of stay for these infants also provided valuable clinical
information.
FUTURE RESEARCH
It would be useful to approach sodium administration in a randomized
controlled study using the approaches established previously such as delaying
the administration of sodium until diuresis occurs and serum sodium is less than
130-135 mmol/L in order to prevent fluid overload. After this diuresis, two
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study groups could be formed, controlling for morbidities and level of sodium
administration. Methods for documenting inadvertent sodium administration
should be implemented in order to quantify total sodium throughout the stay
ruling out extra sodium as a cause for morbidities experienced by preterm
infants.
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Appendix A
Nutrition Composition of Enteral Feeds
Protein
(g)

Iron
(mg)

Calcium
(mg)

Vit D
(IU)

Zinc
(mg)

Na
(mEq)

K
(mEq)

20

Human Milk20 (HM), Mature

1.54

0.04

41

3

0.18

1.1

2

22

HM20+Similac HMF2 (50mL:1
pkt)

2.1

0.3

115

83

0.8

1.5

2.9

24

HM20+SHMF4 (25mL:1 pkt)

2.5

0.5

177

149

1.4

1.7

3.6

27

HM20+SHMF4+Neo3/EnfaCare3

2.3

0.6

169/171

140

1.4/1.3

1.7

3.6/3.5

30

HM20+SHMF4+Neo6/Enfa6

2.5

0.7

163/166

133/134

1.3

1.7

3.6/3.5

24

HM20+Neo4/EnfaCare4

1.7

0.3

51/54

14

0.4/0.3

1.2

2.3/2.1

27

HM20+Neo7/EnfaCare7

1.8

0.5

57/61

20

0.4

1.2/1.3

2.4/2.2

30

HM20+Neo10/EnfaCare10

1.9

0.6

62/67

25

0.5

1.2/1.3

2.5/2.2

20

Enfamil Premature Lipil (PE)

3

1.8

165

240

1.5

2.5

2.5

24

PE High Protein24

3.5

1.8

165

240

1.5

2.5

2.5

27

PE High Protein24+SC30 (1:1)

3.25

1.8

173

195

1.5

2.2

2.9

3

1.8

180

150

1.5

1.9

3.3

20,
Similac Spec Care Adv (SC)
30
24

SC High Protein24

3.3

1.8

180

150

1.5

1.9

3.3

27

SC High Protein24+SC30 (1:1)

3.15

1.8

180

150

1.5

1.9

3.3

EnfaCare

2.8

1.8

120

70

1.3

1.5

2.7

NeoSure

2.8

1.8

105

70

1.2

1.4

3.6

Enfamil

2.1

1.8

78

60

1

1.2

2.8

GoodStart

2.2

1.5

67

60

0.8

1.2

2.8

Similac

2.1

1.8

78

60

0.8

1

2.7

Alimentum

2.8

1.8

105

45

0.8

1.9

3

Nutramigen

2.8

1.8

94

50

1

2

2.8

Pregestimil (50% MCT oil)

2.8

1.8

94

50

1

2

2.8

Elecare for Infants

3.1

1.5

116

60

0.8

2

3.9

Neocate Infant (33% MCT oil)

3.1

1.9

124

60

1.7

1.6

4

Nutramigen AA

2.8

1.8

94

50

1

2

2.8

EnfaPort (84% MCT oil)

3.5

1.8

94

50

1

1.3

2.9

≤
30
≤
30
≤
30
≤
30
≤
30
≤
24
≤
24
≤
24
≤
24
≤
24
≤
30
≤
30

41

Appendix B
Data Abstraction Tools
ID Number:
Day of Life
0
1
Yesterday
4
Yesterday
7
Yesterday
14
Yesterday
21
Yesterday
28
Yesterday
35
Yesterday
42
Yesterday
56
Yesterday
70
Yesterday
84
Yesterday

Sodium from TPN
Date

Amount (mEq)

42

Serum Sodium

Sodium from Medications and Intravenous Solutions
Day
of
Life
0
1
4
7
14
21
28
35
42
56
70
84
Day
of
Life
0
1
4
7
14
21
28
35
42
56
70
84

Date

Medication

Amt
Rec

Medication

Amt
Rec

Medication

Date

Medication

Amt
Rec

Medication

Amt
Rec

Medication
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Appendix C
Sodium Amounts in Medications (41)
Medications that
contain zero
sodium
Amlodipine
Caffeine Citrate
Cefepime
Chlorothiazide
Clindamycin
Dexamethasone
Diuril
Dobutamine
Dopamine
Ergocalciferol
Fat Emulsion
Fentanyl 200 mcg
fentanyl 50 mcg
Fentanyl 500 mcg
Fentanyl bolus
FeSO4
Fluconazole
Ibuprofen
Inositol
Intralipid
Morphine
Polyvisol w/ Iron
Potassium
Chloride

Medication
Omeprazole
3% NS
Na Bicarbonate
Aquadek
Packed RBC
Platelets
Ampicillin

Amount
200
51.3
50
43
31.3
30.5
29

Ceftazidime
Fresh Frozen
Plasma
Meropenum
Dopamine w/
NaCL 0.9
0.9% NS
Plasmanate
Saline Flush
(0.9%NS)
Cosyntropin
Fentanyl w NaCL
0.9%
Metaclopramide
Hydralazine
Albumin, 25%
Phenobarbitol
Metronidazole
Lasix
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Medication
Furosemide
LR, D5
LR
Oxacillin
Indocin
Midazolam
cefotaxime
10 mEq
21.85 Na/100

17.2 8 mEq Na/100
15.455 0.45% NS
4.6 mEq
15.4 Na/100
15.4 23.4% NaCl
15.4 4 mEq Na/100
15.4 Amphoterin B
15.34 0.225% NS
Vecuronium
15.04 10 mg vial
15 2 mEq Na/100
14.63 Tylenol
14.5 hydrocortisone
14.168 Heparin 100 u
14 Gentamicin
13.86 Heparin 25 u

Amount
13.86
13
13
12.5
12.32
10
10
10
8
7.7
4.6
4.003
4
3.7
3.4
3
2
1.74
0.3
0.154
0.054
0.0385
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